Journals
Publish with us
Publishing partnerships
About us
Blog
Chemotherapy Research and Practice
Table of Contents
Special Issues
Chemotherapy Research and Practice
/
2017
/
Article
/
Fig 1
/
Clinical Study
Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?
Figure 1
Estimated progression-free survival in the 2 cohorts.